Literature DB >> 18991069

Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells.

Chaoyang Wang1.   

Abstract

To prolong the transient gene expression mediated by baculoviral vector, the inverted terminal repeats and Rep gene of adeno-associated virus were incorporated into the genome of baculovirus, creating a hybrid baculovirus-adeno-associated viral (AAV) vector. By using previously constructed composite neuron-specific and astrocyte-specific promoters in this hybrid viral vector, sustained transgene expressions could be achieved in human neuronal and glial cell lines, but not in the correspondent rodent cell lines. This hybrid baculovirus-AAV vector might be useful for gene therapy of chronic neurological diseases in the central nervous system, such as Parkinson's disease and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991069     DOI: 10.1080/13550280802290606

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  17 in total

Review 1.  Gene therapy in the CNS.

Authors:  L C Costantini; J C Bakowska; X O Breakefield; O Isacson
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

Review 2.  Recombinant baculoviruses as mammalian cell gene-delivery vectors.

Authors:  Thomas A Kost; J Patrick Condreay
Journal:  Trends Biotechnol       Date:  2002-04       Impact factor: 19.536

Review 3.  Viral vectors as tools to model and treat neurodegenerative disorders.

Authors:  N Déglon; P Hantraye
Journal:  J Gene Med       Date:  2005-05       Impact factor: 4.565

4.  Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.

Authors:  C Y Wang; S Wang
Journal:  Gene Ther       Date:  2006-05-25       Impact factor: 5.250

Review 5.  Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.

Authors:  Joshua C Grieger; Richard J Samulski
Journal:  Adv Biochem Eng Biotechnol       Date:  2005       Impact factor: 2.635

Review 6.  Therapeutic gene transfer to the nervous system using viral vectors.

Authors:  Joseph C Glorioso; Marina Mata; David J Fink
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 7.  Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy.

Authors:  Thomas Carlsson; Tomas Björklund; Deniz Kirik
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

Review 8.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

Authors:  Douglas M McCarty; Samuel M Young; R Jude Samulski
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

9.  Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.

Authors:  J Segovia; P Vergara; M Brenner
Journal:  Gene Ther       Date:  1998-12       Impact factor: 5.250

Review 10.  Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy.

Authors:  Sudip Ghosh; Md Khalid Parvez; Kakoli Banerjee; Shiv K Sarin; Seyed E Hasnain
Journal:  Mol Ther       Date:  2002-07       Impact factor: 11.454

View more
  1 in total

1.  Highly efficient transduction of primary adult CNS and PNS neurons.

Authors:  Evgeny Levin; Heike Diekmann; Dietmar Fischer
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.